Back to Screener

Omnicell Inc (OMCL)

Price$41.89
Value ScoreB
Growth ScoreD
Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)2.06%
Price vs S&P 500 (4W)-8.73%
VGM Score45.93
Market Capitalization$1.93B
P/E Ratio (Annual)938.83x

All Metrics

P/CF (Annual)15.13x
Book Value / Share (Quarterly)$27.63
P/TBV (Annual)2.02x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-2.94%
Cash Flow / Share (Quarterly)$2.10
Price vs S&P 500 (YTD)-18.87%
Gross Margin (TTM)43.50%
Net Profit Margin (TTM)1.67%
EPS (TTM)$0.44
10-Day Avg Trading Volume0.47M
EPS Excl Extra (TTM)$0.44
Revenue Growth (5Y)5.84%
EPS (Annual)$0.04
ROI (Annual)0.15%
Gross Margin (Annual)42.88%
Net Profit Margin (5Y Avg)1.36%
Cash / Share (Quarterly)$5.58
P/E Basic Excl Extra (TTM)94.28x
Revenue Growth QoQ (YoY)14.91%
EPS Growth (5Y)-43.01%
P/E Normalized (Annual)938.83x
ROA (Last FY)0.10%
Revenue Growth TTM (YoY)7.86%
EBITD / Share (TTM)$2.42
ROE (5Y Avg)1.35%
Operating Margin (TTM)2.75%
Cash Flow / Share (Annual)$1.49
P/B Ratio1.53x
P/B Ratio (Quarterly)1.21x
Net Income / Employee (Annual)$600
EV / Revenue (TTM)1.51x
Net Interest Coverage (TTM)-24.00x
ROA (TTM)1.01%
EV / EBITDA (TTM)16.71x
EPS Incl Extra (Annual)$0.04
Current Ratio (Annual)1.43x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume0.63M
52-Week Price Return38.77%
EV / Free Cash Flow (Annual)27.71x
P/E Incl Extra (TTM)94.28x
Revenue / Employee (TTM)$342,200
Tangible BV / Share (Quarterly)$22.83
P/S Ratio (Annual)1.63x
Asset Turnover (Annual)0.60x
52-Week High$55.00
Operating Margin (5Y Avg)1.03%
EPS Excl Extra (Annual)$0.04
CapEx CAGR (5Y)1.92%
Tangible BV CAGR (5Y)7.39%
26-Week Price Return15.65%
Quick Ratio (Annual)1.14x
13-Week Price Return1.60%
Total Debt / Equity (Annual)0.14x
Current Ratio (Quarterly)1.50x
Enterprise Value$1.86B
Revenue / Share Growth (5Y)4.59%
Asset Turnover (TTM)0.61x
Book Value / Share Growth (5Y)3.89%
Revenue / Employee (Annual)$331,000
Inventory Turnover (Annual)7.14x
Pretax Margin (Annual)0.96%
Cash / Share (Annual)$4.69
3-Month Return Std Dev56.47%
Gross Margin (5Y Avg)44.86%
Net Income / Employee (TTM)$5,700
EBITDA CAGR (5Y)-2.77%
EBITDA Interim CAGR (5Y)-0.97%
ROE (Last FY)0.17%
Net Interest Coverage (Annual)6.18x
EPS Basic Excl Extra (Annual)$0.04
P/FCF (TTM)20.20x
Receivables Turnover (TTM)4.89x
EV / Free Cash Flow (TTM)19.45x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$0.44
Receivables Turnover (Annual)5.01x
ROI (TTM)1.40%
P/S Ratio (TTM)1.57x
Pretax Margin (5Y Avg)1.43%
Revenue / Share (Annual)$25.56
Tangible BV / Share (Annual)$22.38
Forward P/E21.73x
Free OCF CAGR (5Y)-12.57%
Price vs S&P 500 (52W)10.62%
P/E Ratio (TTM)94.28x
EPS Growth TTM (YoY)-2.43%
Year-to-Date Return-7.48%
5-Day Price Return-2.81%
EPS Normalized (Annual)$0.04
ROA (5Y Avg)0.73%
Net Profit Margin (Annual)0.17%
Month-to-Date Return-5.05%
Cash Flow / Share (TTM)$1.18
EBITD / Share (Annual)$1.81
EPS Growth (3Y)-28.66%
Operating Margin (Annual)0.44%
LT Debt / Equity (Annual)0.14x
P/CF (TTM)12.36x
ROI (5Y Avg)0.97%
P/E Excl Extra (TTM)94.28x
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$0.44
P/TBV (Quarterly)1.46x
P/B Ratio (Annual)1.65x
Inventory Turnover (TTM)7.27x
Pretax Margin (TTM)3.08%
Book Value / Share (Annual)$27.36
Price vs S&P 500 (13W)-9.06%
Net Margin Growth (5Y)-45.73%
Beta0.97x
P/FCF (Annual)28.78x
Revenue / Share (TTM)$26.66
ROE (TTM)1.64%
52-Week Low$26.85
vGradeB
gGradeD
mGradeC
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.55est. 0.34

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
3.93
4.07
4.07
4.07

About

Omnicell Inc develops automation and analytics software that streamlines medication management for healthcare providers. The company's solutions enable pharmacists and nurses to reduce administrative work while improving patient care and driving better clinical, operational, and financial outcomes. Revenue is primarily generated from the United States market.